Showing results (121-130 of 370) with videos related to
Sort By:
Pageof 37
European Urology|June 15, 2012
A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladderEliot H Ohlstein, Alexander von Keitz, Martin C MichelMolecular Pharmacology|December 29, 2019
New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental BiologyMartin C Michel, T J Murphy, Harvey J MotulskyDrug Metabolism and Disposition: the Biological Fate of Chemicals|December 29, 2019
New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental BiologyMartin C Michel, T J Murphy, Harvey J MotulskyNeurourology and Urodynamics|January 17, 2020
Do overactive bladder symptoms and their treatment-associated changes exhibit a normal distribution? Implications for analysis and reportingMarjan Amiri, Sandra Murgas, Andreas Stang, et al.Cells|December 1, 2020
Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic HeartBetul R Erdogan, Martin C Michel, Ebru Arioglu-InanNeurourology and Urodynamics|May 20, 2022
Associations between the Patient Perception of Bladder Condition score and overactive bladder syndrome symptoms at baseline and upon treatmentSandra Schönburg, Sandra Murgas, Paolo Fornara, et al.Journal of Clinical Medicine|November 11, 2022
Self-Medication for the Treatment of Abdominal Cramps and Pain-A Real-Life Comparison of Three Frequently Used PreparationsMartin Storr, Harald Weigmann, Sabine Landes, et al.The Journal of Pharmacology and Experimental Therapeutics|December 30, 2019
New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental BiologyMartin C Michel, T J Murphy, Harvey J MotulskyPulmonary Therapy|May 7, 2020
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy VolunteersCeline Ollier, Ulrike Sent, Margarida Mesquita, et al.Trends in Pharmacological Sciences|July 28, 2006
Rho kinase: a target for treating urinary bladder dysfunction?Stephan L M Peters, Martina Schmidt, Martin C MichelPageof 37